Diabetes Is Primary Live Webinar—Misdiagnosing LADA as Type 2 Diabetes Follow Up Q&A

Welcome to our follow-up Q&A session! In this video, we are addressing the questions that could not be answered during the live webinar. Our expert panel takes a deep dive into the topics you care about, providing clarity and additional insights on key points discussed during the live session.

If you missed the live webinar, don’t worry! You can still watch the on-demand recording on ADA's Institute of Learning, and this Q&A session will help expand on some of the most pressing questions from the audience.



Topics covered in this video:

0:00 Intro

1:02 High A1C and Firstline Medication

3:00 The Use of Metformin in Patients with Colitis

4:03 The ADA’s Standards of Care App

5:16 Confirming Diagnosis with GAD & C-Peptide

6:15 Insurance Coverage of GAD & C-Peptide Testing

7:20 Metformin Continuation with the Initiation of Insulin

12:00 Referring to Diabetes Education

14:14 Professional CGM Use

15:10 CGM Technology Use

17:49 Avoiding and Overcoming Therapeutic Inertia

20:08 Basal Insulin Initiation in Patients with LADA

22:24 FreeStyle Libre 3 Recall

23:00 TZield Use

23:52 Basal Insulin Use in a patient with recent low C-Peptide & positive GAD

24:58 Reliability of the A1C Test

27:00 GMI vs A1C

28:17 CGM Reports

33:47 Charging for CGM Interpretation

37:15 Does every patient with diabetes need to be referred to endocrinology?

39:09 ERP Directory and the ADA’s Standard of Care App

40:10 Medicare Coverage of DSMES

41:17 Billing for 10 Hours of Non-MNT Education

42:17 Billing In Between Visits

46:17 Barriers to Diabetes Education

51:02 Education Clinics on Diabetes Education

53:11 Culturally Diverse Resources

57:29 Fasting Recommendations

1:00:00 Mindfulness & Intuitive Eating

1:03:54 Overcoming the Sugary Soda Struggle Bus

1:05:12 How Fat & Protein Effect Blood Glucose